Literature review · Muscle & strength / Ageing & cellular health / Metabolism & weight

MOTS-c

MOTS-c has mechanistic and mouse-intervention evidence involving metabolic signalling and physical performance. The human exercise observations cited here concern naturally occurring MOTS-c, not a trial of a purchased peptide.

By HeartPep · Reviewed · 2 selected source records

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

At a glance

Two selected primary studies connect cell pathways with mouse physiology. Human measurements in the later paper add biological context, but do not demonstrate that supplementing MOTS-c improves human strength, weight or lifespan.

Identity & scope

The foundational study describes MOTS-c as a 16-amino-acid peptide encoded by a short open reading frame associated with mitochondrial 12S rRNA. A supplier label alone does not verify the sequence of supplied material.

Catalogue labels covered: MOTS-c; MOTS-C.

What the research shows

  • Lee and colleagues linked MOTS-c to folate/purine metabolism and AMPK signalling, alongside metabolic changes in mice.
  • Reynolds and colleagues reported performance changes in treated mice and exercise-associated changes in endogenous MOTS-c in ten young men.

Critical interpretation

Separate the human observation from the animal intervention

The exercise observations establish an association with an endogenous signal under the studied conditions. They do not supply the missing comparison between people assigned to a supplied peptide and people assigned to a control. Our interpretation is that an adaptive exercise response may identify a useful biological pathway while leaving supplementation efficacy unresolved. Treating the observation as a treatment trial would erase that distinction. [2]

Mechanistic coherence is useful, but insufficient

Linking cellular pathways with physiological changes in mice is stronger than a mechanism-only speculation, because it provides several testable levels of evidence. It still requires scrutiny of model selection, exposure measurement and whether the proposed pathway is necessary for the observed phenotype. Replication with prospectively specified outcomes would be more informative than simply adding further pathway measurements to a favourable model. [1] [2]

What would make translation convincing?

A useful next step would preserve the exact sequence and analytical specification, establish relevant human exposure and test a defined functional outcome. Fitness, body composition and lifespan are separate endpoints. A result on one should not be used as an unmeasured answer to the others. We therefore treat the current selected evidence as a basis for research hypotheses rather than a demonstrated human performance effect. [1] [2]

Limitations & uncertainties

  • Observation of an exercise response is different from randomising people to receive an intervention.
  • Mouse performance and healthspan measurements do not establish human lifespan extension or clinical weight management.
  • The selected studies do not validate the identity, exposure, effectiveness or safety of HeartPep vial or nasal products.

Open research questions

  • Can independently replicated human intervention studies establish a clinically meaningful effect?
  • Which study materials, analytical methods and exposure measurements would allow a valid formulation comparison?

Selected papers & source records

Download bibliography
Animal studyNamed compoundAbstract / record checked

1. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance (opens in a new tab)

Lee C, Zeng J, Drew BG, et al. (2015). Cell Metabolism. DOI: 10.1016/j.cmet.2015.02.009 (opens in a new tab) · PMID 25738459

Design & population
Mechanistic cell experiments and mouse models of ageing and high-fat-diet-associated metabolic dysfunction.
What the study found
Reported AMPK-associated metabolic signalling and prevention of insulin resistance and diet-induced obesity in the studied mouse models.
Limits on interpretation
Preclinical intervention evidence. It does not demonstrate human treatment effects or validate a commercial formulation.
Animal studyNamed compoundAbstract / record checked

2. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis (opens in a new tab)

Reynolds JC, Lai RW, Woodhead JST, et al. (2021). Nature Communications. DOI: 10.1038/s41467-020-20790-0 (opens in a new tab) · PMID 33473109

Design & population
Mouse intervention and muscle/cell experiments, with exercise-related human measurements in ten young men.
What the study found
Reported enhanced physical capacity in mice and an exercise-associated rise in naturally occurring MOTS-c in human muscle and blood.
Limits on interpretation
The human component was not a peptide-treatment trial. Study authors disclosed relevant commercial interests.

Search & review scope

Targeted primary-record review using PubMed, PMC and publisher records, starting with existing HeartPep references and selected additional searches.. Checked 9 November 2026.

Foundational metabolic study and a later muscle/ageing study, separating mouse intervention from human exercise observation.

Selected narrative evidence review, not a systematic search or meta-analysis. Abstract-led unless an individual record is marked full-text. No claim that all studies, registries or unpublished results were searched. Searches can return exercise or heat studies that measure endogenous MOTS-c; these must not be counted as trials administering MOTS-c. Direct full-text retrieval was intermittent, and full methods were not comprehensively audited. Linked notices and targeted correction/retraction searches were checked where accessible. This is not a complete publication-status or raw-data audit; missing search results do not certify that a paper has no updates.

Recorded search terms
  • 25738459 MOTS-c Lee 2015 Cell metabolism Pubmed
  • "MOTS-c" randomized human trial 2025 2026
  • MOTS-c Reynolds 2021 correction retraction 33473109
  • "10.1016/j.cmet.2015.02.009" correction retraction

Read the collection’s methods and editorial limits. For formal research, assess and cite the original paper.

Cite this review

HeartPep. MOTS-c: literature review. HeartPep literature library. Reviewed 9 November 2026. https://heartpep.com/uk/research/library/mots-c.

HeartPep is the commercial publisher of this secondary summary. It is not a peer-reviewed primary paper. Cite the original studies for their findings.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

← All reviews and reference notes